DrugPatentWatch Database Preview

Nexgen Pharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for NEXGEN PHARMA INC, and what generic and branded alternatives to NEXGEN PHARMA INC drugs are available?

NEXGEN PHARMA INC has fifteen approved drugs.

Summary for Nexgen Pharma Inc

US Patents:	0
Tradenames:	14
Ingredients:	14
NDAs:	15

Drugs and US Patents for Nexgen Pharma Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nexgen Pharma Inc	ISONIAZID	isoniazid	TABLET;ORAL	084050-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Nexgen Pharma Inc	DIPHENHYDRAMINE HYDROCHLORIDE	diphenhydramine hydrochloride	CAPSULE;ORAL	083634-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Nexgen Pharma Inc	SODIUM PENTOBARBITAL	pentobarbital sodium	TABLET;ORAL	084238-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Nexgen Pharma Inc	BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE	acetaminophen; butalbital; caffeine; codeine phosphate	CAPSULE;ORAL	076560-001	Jun 10, 2004	AB	RX	No	No
Nexgen Pharma Inc	POLYETHYLENE GLYCOL 3350	polyethylene glycol 3350	FOR SOLUTION;ORAL	077706-001	Sep 27, 2006	AA	RX	No	No
Nexgen Pharma Inc	FOLIC ACID	folic acid	TABLET;ORAL	084915-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Nexgen Pharma Inc	DIMENHYDRINATE	dimenhydrinate	TABLET;ORAL	085985-001	Approved Prior to Jan 1, 1982		DISCN	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Nexgen Pharma
• Nexgen Pharma Inc